摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(乙酰氧基(2-氟苯基)甲基)丙烯酸乙酯 | 351352-28-8

中文名称
2-(乙酰氧基(2-氟苯基)甲基)丙烯酸乙酯
中文别名
——
英文名称
ethyl 2-(acetoxy(2-fluorophenyl)methyl)acrylate
英文别名
Ethyl 2-[acetyloxy-(2-fluorophenyl)methyl]prop-2-enoate
2-(乙酰氧基(2-氟苯基)甲基)丙烯酸乙酯化学式
CAS
351352-28-8
化学式
C14H15FO4
mdl
——
分子量
266.269
InChiKey
LIZSQUIDQXGDME-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    347.9±42.0 °C(Predicted)
  • 密度:
    1.167±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.6
  • 重原子数:
    19
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    52.6
  • 氢给体数:
    0
  • 氢受体数:
    5

SDS

SDS:115eb1f4e16848fc9943eb951ae7fd91
查看

反应信息

点击查看最新优质反应信息

文献信息

  • A Facile Synthesis of 3-Methylene-4-aryl-1,3,4,5-tetrahydrobenzo[<i>b</i>][1,4]di­azepin-2-ones and 3-Arylmethylene-4,5-dihydro-3<i>H</i>-benzo[<i>b</i>][1,4]diazepin-2-ylamines
    作者:S. Batra、R. Pathak、S. Nag
    DOI:10.1055/s-2006-950352
    日期:——
    A simple and convenient synthesis of 3-methylene-4-aryl-1,3,4,5-tetrahydrobenzo[b][1,4]diazepin-2-ones was accomplished by the SN2 nucleophilic substitution of the acetates of Baylis­-Hillman adducts of acrylate with 1,2-phenylenediamines, followed by base-mediated intramolecular cyclization. Similar substrates derived from the Baylis-Hillman adducts of acrylonitrile via Pinner’s reaction led to 3-arylmethylene-4,5-dihydro-3H-benzo[b][1,4]diazepin-2-ylamines in good yields.
    一种简单方便的合成3-亚甲基-4-芳基-1,3,4,5-四氢苯并[b][1,4]二氮杂平-2-酮的方法,通过丙烯酸盐的Baylis-Hillman加成产物的醋酸酯与1,2-苯二胺的SN2亲核取代反应实现,随后进行碱介导的分子内环化。通过Pinner反应从丙烯腈的Baylis-Hillman加成产物衍生的类似底物,也能够以良好的产率合成3-芳基亚甲基-4,5-二氢-3H-苯并[b][1,4]二氮杂平-2-基胺。
  • INDOLIZINONE BASED DERIVATIVES AS POTENTIAL PHOSPHODIESTERASE 3 (PDE3) INHIBITORS AND A PROCESS FOR THE PREPARATION THEREOF
    申请人:COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    公开号:US20140296530A1
    公开(公告)日:2014-10-02
    The present invention provides compounds of general formula A useful as potential phosphodiesterase3 (PDE3) inhibitory agents and a process for the preparation thereof. The derivatives of formula A can be employed as therapeutics in human and veterinary medicine, where they can be used, for example, for the treatment and prophylaxis of the following diseases: heart failure, dilated cardiomyopathy, platelet inhibitors, cancer and obstructive pulmonary diseases.
    本发明提供了一般式A的化合物,作为潜在的磷酸二酯酶3(PDE3)抑制剂,并提供了其制备方法。一般式A的衍生物可用作人类和兽医药学中的治疗剂,例如可用于治疗和预防以下疾病:心力衰竭、扩张型心肌病、血小板抑制剂、癌症和阻塞性肺部疾病。
  • PYRIDOPYRIMIDINE BASED DERIVATIVES AS POTENTIAL PHOSPHODIESTERASE 3 (PDE3) INHIBITORS AND A PROCESS FOR THE PREPARATION THEREOF
    申请人:COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH
    公开号:US20140221651A1
    公开(公告)日:2014-08-07
    The present invention provides compounds of formula 1 as potential phosphodiesterase3 (PDE3) inhibitory agents and a process for the preparation thereof. The derivatives of formula 1 can be employed as therapeutics in human and veterinary medicine, where they can be used, for the treatment and prophylaxis of the following diseases: heart failure, dilated cardiomyopathy, platelet inhibitors, cancer and obstructive pulmonary diseases. Where in X=H, alkyl, aryl, heteroaryl Y=H, alkyl, aryl, heteroaryl R=substituted phenyl A=H, alkyl, alkoxy, halo, dihalo B=H, alkyl, alkoxy, halo, dihalo C=H, alkyl, alkoxy, halo, dihalo
    本发明提供了公式1的化合物作为潜在的磷酸二酯酶3(PDE3)抑制剂,并提供了其制备方法。公式1的衍生物可以作为人类和兽医药学中的治疗药物使用,用于治疗和预防以下疾病:心力衰竭、扩张型心肌病、血小板抑制剂、癌症和阻塞性肺部疾病。其中,X=H、烷基、芳基、杂环芳基;Y=H、烷基、芳基、杂环芳基;R=取代苯基;A=H、烷基、烷氧基、卤素、二卤代基;B=H、烷基、烷氧基、卤素、二卤代基;C=H、烷基、烷氧基、卤素、二卤代基。
  • Trifluoroacetic acid: a more effective and efficient reagent for the synthesis of 3-arylmethylene-3,4-dihydro-1H-quinolin-2-ones and 3-arylmethyl-2-amino-quinolines from Baylis–Hillman derivatives via Claisen rearrangement
    作者:Richa Pathak、Sudharshan Madapa、Sanjay Batra
    DOI:10.1016/j.tet.2006.10.053
    日期:2007.1
    Trifluoroacetic acid has been discovered to be a highly effective and efficient reagent for the tandem Claisen rearrangement and cyclization reaction to yield 3-arylmethylene-3,4-dihydro-1H-quinolin-2-ones from compounds obtained from the SN2 reaction between anilines and acetyl derivatives of Baylis–Hillman adducts of acrylates in the presence of DABCO. In contrast, similar compounds obtained from
    已经发现三氟乙酸是用于串联克莱森重排和环化反应以从由S N 2反应获得的化合物产生3-芳基亚甲基-3,4-二氢-1 H-喹啉-2-酮的高效和高效试剂。DABCO存在下苯胺丙烯酸Bayis-Hillman加合物的乙酰基衍生物之间的关系。相反,在三氟乙酸处理下,从Baylis-Hillman丙烯腈加成物的乙酰基衍生物获得的类似化合物通过串联Claisen重排,环化和异构化直接提供3-芳基甲基-2-基-喹啉
  • Synthesis of N-substituted 1,4-dihydroquinolines from the Baylis–Hillman acetates via the successive SN2′–SNAr isomerization strategy
    作者:Jae Nyoung Kim、Hyoung Shik Kim、Ji Hyeon Gong、Yun Mi Chung
    DOI:10.1016/s0040-4039(01)01791-9
    日期:2001.11
    1,4-Dihydroquinolines 4a–e were prepared from the reaction of the Baylis–Hillman acetates of ortho-halobenzaldehydes and benzylamine or cyclohexylamine via the successive SN2′–SNAr isomerization strategy.
    1,4-二氢喹啉4A - Ë是从的Baylis-希尔曼反应制备的乙酸盐邻-halobenzaldehydes并经由连续小号苄胺环己胺ñ 2'-S Ñ异构化策略。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫